Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus.

MLA

Jenkinson, Claire, et al. “Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 22, no. 7, Apr. 2016, pp. 1734–43. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-15-0879.

APA

Jenkinson, C., Elliott, V. L., Evans, A., Oldfield, L., Jenkins, R. E., O’Brien, D. P., Apostolidou, S., Gentry-Maharaj, A., Fourkala, E.-O., Jacobs, I. J., Menon, U., Cox, T., Campbell, F., Pereira, S. P., Tuveson, D. A., Park, B. K., Greenhalf, W., Sutton, R., Timms, J. F., … Costello, E. (2016). Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(7), 1734–1743. https://doi.org/10.1158/1078-0432.CCR-15-0879

Chicago

Jenkinson, Claire, Victoria L Elliott, Anthony Evans, Lucy Oldfield, Rosalind E Jenkins, Darragh P O’Brien, Sophia Apostolidou, et al. 2016. “Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 22 (7): 1734–43. doi:10.1158/1078-0432.CCR-15-0879.